Baoyuan Zhang Ph.D.

Mr. Baoyuan Zhang joined InxMed in Sept 2019 as Senior Director, Translational Medicine. He has rich work experience in innovative drug research and translational medicine. He previously worked in Chempartner and WuXi AppTec, and acted as senior scientist for translational research and bioinformatics in the oncology department. Dr. Baoyuan Zhang graduated from the University of Macau to lead the project entitled “Synthetic lethality discovery for BRCA1 deficient breast cancer”. The project won the best research award at the Korean Biomedical Conference, in 2017. He has already published 15 scientific research articles as first author or corresponding author in top-tier journals including Advanced Science, Nature Communications, Cancer Research, and Oncogene. Dr. Baoyuan Zhang holds a bachelor's degree in biochemistry, a master's degree in pharmacology, and a Ph. D. in biomedical science.

Mr. Baoyuan Zhang joined InxMed in Sept 2019 as Sr Director, translational medicine. He has rich work experience in innovative drug research and translational medicine. He previously worked in Chempartner and WuXi AppTec, and acted as senior scientist for translational research and bioinformatics in the oncology department. Dr. Baoyuan Zhang graduated from the University of Macau to lead the project entitled “Synthetic lethality discovery for BRCA1 deficient breast cancer”. The project won the best research award at the Korean Biomedical Conference, in 2017. He has already published 15 scientific research articles as first author or corresponding author in top-tier journals including Advanced Science, Nature Communications, Cancer Research, and Oncogene. Dr. Baoyuan Zhang holds a bachelor's degree in biochemistry, a master's degree in pharmacology, and a Ph. D. in biomedical science.